Clinical Trials Browser

Phase NA × apatinib × Sarcoma × Clear all

NCT05751733 2023-03-02

Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST

Phase NA Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04690231 2022-03-15

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Phase NA Completed

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04260113 2021-01-05

AIAC

Phase NA Completed

Chondrosarcoma, Drug-Related Side Effects and Adverse Reactions